Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-069973
Filing Date
2014-11-20
Accepted
2014-11-20 11:19:00
Documents
1
Period of Report
2014-11-18

Document Format Files

Seq Description Document Type Size
1 form471639_20141120111758-.html 4  
1 form471639_20141120111758-.xml 4 6433
  Complete submission text file 0001144204-14-069973.txt   8043
Mailing Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807
Business Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807 908-864-4444
Sevion Therapeutics, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address WAKSAL CONSULTING LLC 7 NORTH WILLOW STREET, SUITE 6 MONTCLAIR NJ 07042
Business Address
Waksal Harlan (Reporting) CIK: 0001449008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 141237990